Worldquant Millennium Advisors LLC Purchases Shares of 3,401 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Worldquant Millennium Advisors LLC acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 3,401 shares of the medical equipment provider's stock, valued at approximately $1,775,000.

Other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of Intuitive Surgical by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after acquiring an additional 360,591 shares during the period. Geode Capital Management LLC boosted its stake in Intuitive Surgical by 3.2% in the fourth quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock valued at $4,039,200,000 after acquiring an additional 243,802 shares in the last quarter. Fisher Asset Management LLC boosted its stake in Intuitive Surgical by 1.8% in the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock valued at $2,541,356,000 after acquiring an additional 86,488 shares in the last quarter. Norges Bank acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $2,401,493,000. Finally, Invesco Ltd. lifted its stake in shares of Intuitive Surgical by 7.7% during the fourth quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock worth $2,165,184,000 after buying an additional 295,025 shares during the period. Institutional investors own 83.64% of the company's stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director now owns 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the company's stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. This represents a 60.72% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 32,700 shares of company stock valued at $16,865,621 over the last ninety days. Insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded up $4.22 during midday trading on Wednesday, hitting $554.41. 314,240 shares of the company's stock traded hands, compared to its average volume of 1,640,057. The company has a market cap of $198.71 billion, a PE ratio of 86.48, a P/E/G ratio of 5.85 and a beta of 1.70. The firm's fifty day moving average price is $513.67 and its two-hundred day moving average price is $538.20. Intuitive Surgical, Inc. has a twelve month low of $396.15 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the business posted $1.50 EPS. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the stock a "buy" rating in a research note on Monday, April 14th. Evercore ISI lowered their price objective on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research note on Wednesday, April 23rd. Robert W. Baird lowered their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Erste Group Bank cut shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. Finally, Piper Sandler cut their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average target price of $596.05.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.